Funds advised by Apax Partners and Fremman Capital are to jointly acquire co-controlling stakes in Palex Medical, from funds advised by current majority shareholder Fremman, and other minority shareholders in a deal that values the business at around €1bn.
OAG, the provider of a data platform for the global travel industry, has acquired Infare, a provider of competitor air travel data, from private equity firm Ventiga Capital in a deal valuing the combined entity at over $500m.
Epiris, via Epiris Fund III, is to acquire Pure Cremation, a provider of prepaid funeral plans in the UK. The deal, Fund III’s third investment, is subject to regulatory approval and is expected to complete before the end of this year. Financial terms have not been disclosed.
Thirty four new private credit funds raised a combined $71.2bn in capital commitments in the second quarter of the year, more than double the figure raised in the previous three months, according to a report by Bloomberg.
After a prolonged deal-making slump, private equity transactions are beginning to be fuelled by an “explosion of private debt”, according to Ken Jacobs, the Chief Executive Officer of Lazard, a financial advisory and asset management firm and one of the world’s largest private banks. A report by Bloomberg quotes Jacobs
Palamon Capital Partners, a pan-European private equity firm based in London, has completed the sale of 24 ORE Business School to Digit’Ed, an Italian managerial training hub owned by Nextalia Private Equity Fund.
Palatine has added to its Manchester-based team with the appointment of Rachael Taplin as an Investment Manager for its Impact Fund. Taplin joins from Grant Thornton, where she spent more than two-and a-half years in the corporate finance team. During her time with Grant Thornton, Taplin advised on several key
Third Eye Capital, a Canada-based provider of asset-based financing solutions to “underserved or overlooked” companies, has appointed David Steele as President and Chief Operating Officer, effective 15 August, 2023.
A/O, one of Europe’s largest venture capital firms primarily focused on investments in built-world technologies, has held the first close of its new flagship fund, which is targeting €250m in capital commitments. Founded in 2019, A/O is committed to investing in technologies that aim to reduce greenhouse gas emissions, build
Kelso & Co and Juggernaut Capital Partners, the private equity backers of Foundation Consumer Healthcare, are considering a potential sale of the company with a price tag of up to $4bn, according to a report by Bloomberg.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
